Our new paper is making headlines!

The latest paper from lab, titled “Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC”, made the news within the first week of publication! You can read some of these news articles and learn more about our impactful research: A ‘one-two punch’ against aggressive breast cancer Read more

Congratulations to Dr. Sahin on his new role as Program Director of Science Translation for the Hollings Advisory for Rapid Translation (HART).

Our PI, Dr. Ozgur Sahin, has accepted the position of Program Director of Science Translation for the Hollings Advisory for Rapid Translation (HART). In this newly created role, he will lead and support strategic initiatives to advance the translation of basic science into investigator-initiated clinical research. We sincerely congratulate him Read more

Two posters in AACR 2025

Kubra presented a poster entitled “Targeting TACC3 inhibits metastasis in breast cancer with centrosome amplification“. Ozge presented a poster entitled “LINC00152-regulated PDE4D mediates drug resistance and metastasis in highly aggressive breast cancer“.